Clinical Trial Update: Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension [NA]

View source ↗

Summary

The SPYRAL SWYFT trial evaluating a renal denervation treatment for uncontrolled hypertension is currently recruiting, sponsored by Medtronic Vascular.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Chronic Kidney Disease
• Diabetes Mellitus
• Hypertension
• Vascular Disease

Drugs mentioned

• spYral

Snippet

Sponsor: Medtronic Vascular | Conditions: Hypertension, Vascular Diseases | NA | Status: RECRUITING